Mpl ligand enhances the transcription of the cyclin D3 gene: A potential role for Sp1 transcription factor

被引:42
作者
Wang, ZY
Zhang, Y
Lu, J
Sun, SS
Ravid, K
机构
[1] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
关键词
D O I
10.1182/blood.V93.12.4208.412k17_4208_4221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cyclin D3 plays a major role in the development of polyploidy in megakaryocytes. The expression of cyclin D3 gene and the level of cyclin D3 protein are increased by the Mpl ligand in the Y10/L8057 megakaryocytic cell line, as indicated by Northern and Western blot analyses, and by nuclear run-on assays and transfection experiments with cyclin D3 promoter constructs. DNase I footprinting of the promoter region showed protected segments, at -75 to -60 bp and at -134 to -92 bp, which display binding sites for the Sp family of transcription factors. Gel mobility shift assay and supershifts with specific antibodies indicate that Sp1 binds to these regions in the cyclin D3 promoter and that Sp1 binding activity is significantly increased by Mpl ligand. Mutation of either Sp1 site both decreases the basal promoter activity and eliminates the induction by Mpl ligand. We find that the nonphosphorylated form of SP1 has greater affinity for the cyclin D3 promoter and that the majority of Sp1 in the cells is nonphosphorylated. Mpl ligand treatment results in increased levels of Sp1 protein, which also appears as nonphosphorylated. Okadaic acid, which inhibits protein phosphatase 1 (PP1) and shifts Sp1 to a phosphorylated form, decreases cyclin D3 gene expression and suppresses Mpl ligand induction. Our data point to the potential of Mpl ligand to activate at once several Sp1-dependent genes during megakaryopoiesis. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:4208 / 4221
页数:14
相关论文
共 77 条
[1]  
ADNANE J, 1995, ONCOGENE, V10, P381
[2]   Casein kinase II-mediated phosphorylation of the C terminus of spl decreases its DNA binding activity [J].
Armstrong, SA ;
Barry, DA ;
Leggett, RW ;
Mueller, CR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (21) :13489-13495
[3]  
AUSUBEL FM, 1995, DNA PROTEIN INTERACT
[4]  
AUSUBEL FM, 1995, IDENTIFICATION NEWLY
[5]   THE RETINOBLASTOMA PROTEIN COPURIFIES WITH E2F-I, AN E1A-REGULATED INHIBITOR OF THE TRANSCRIPTION FACTOR E2F [J].
BAGCHI, S ;
WEINMANN, R ;
RAYCHAUDHURI, P .
CELL, 1991, 65 (06) :1063-1072
[6]   CYCLIN D1 IS A NUCLEAR-PROTEIN REQUIRED FOR CELL-CYCLE PROGRESSION IN G(1) [J].
BALDIN, V ;
LUKAS, J ;
MARCOTE, MJ ;
PAGANO, M ;
DRAETTA, G .
GENES & DEVELOPMENT, 1993, 7 (05) :812-821
[7]   An Ets/Sp1 interaction in the 5'-flanking region of the megakaryocyte-specific alpha IIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene [J].
Block, KL ;
Shou, YP ;
Poncz, M .
BLOOD, 1996, 88 (06) :2071-2080
[8]   PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF THE PROMOTER-SPECIFIC TRANSCRIPTION FACTOR, SPL [J].
BRIGGS, MR ;
KADONAGA, JT ;
BELL, SP ;
TJIAN, R .
SCIENCE, 1986, 234 (4772) :47-52
[9]   Functional analysis of the human cyclin D2 and cyclin D3 promoters [J].
Brooks, AR ;
Shiffman, D ;
Chan, CS ;
Brooks, EE ;
Milner, PG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) :9090-9099
[10]   THE E2F TRANSCRIPTION FACTOR IS A CELLULAR TARGET FOR THE RB PROTEIN [J].
CHELLAPPAN, SP ;
HIEBERT, S ;
MUDRYJ, M ;
HOROWITZ, JM ;
NEVINS, JR .
CELL, 1991, 65 (06) :1053-1061